These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3310585)

  • 21. Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial.
    Pratt CM; Wierman A; Seals AA; English L; Leon C; Young JB; Quinones MA; Roberts R
    Circulation; 1986 Apr; 73(4):718-26. PubMed ID: 3512124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine).
    Morganroth J; Pratt CM
    Am J Cardiol; 1989 Jan; 63(3):172-6. PubMed ID: 2642632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethmozine (moricizine HCl): a promising drug for "automatic" atrial ectopic tachycardia.
    Evans VL; Garson A; Smith RT; Moak JP; McVey P; McNamara DG
    Am J Cardiol; 1987 Oct; 60(11):83F-86F. PubMed ID: 3310591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placement of moricizine in the selection of antiarrhythmic drug therapy.
    Morganroth J
    Am J Cardiol; 1990 Feb; 65(8):65D-67D; discussion 68D-71D. PubMed ID: 2407093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethacizin: a new efficacious Soviet antiarrhythmic drug of the phenothiazine group.
    Rosenshtraukh LV; Shugushev KK; Smetnev AS
    Am Heart J; 1986 Nov; 112(5):932-9. PubMed ID: 3535466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moricizine: a novel antiarrhythmic agent.
    Carnes CA; Coyle JD
    DICP; 1990; 24(7-8):745-53. PubMed ID: 2197817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moricizine: a new class I antiarrhythmic.
    Mann HJ
    Clin Pharm; 1990 Nov; 9(11):842-52. PubMed ID: 2272151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A symposium: Pharmacological management of ventricular arrhythmias--current status in the role of moricizine HCl. October 19-22, 1989, Scottsdale, Arizona. Proceedings.
    Am J Cardiol; 1990 Feb; 65(8):1D-71D. PubMed ID: 2407087
    [No Abstract]   [Full Text] [Related]  

  • 29. The changing base line of complex ventricular arrhythmias. A new consideration in assessing long-term antiarrhythmic drug therapy.
    Pratt CM; Delclos G; Wierman AM; Mahler SA; Seals AA; Leon CA; Young JB; Quinones MA; Roberts R
    N Engl J Med; 1985 Dec; 313(23):1444-9. PubMed ID: 3903506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia.
    Pratt CM; Francis M; Mahler S; Aogaichi K; Keus P; Young JB
    Am Heart J; 1988 Oct; 116(4):897-903. PubMed ID: 2459950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
    Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
    Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine.
    Podrid PJ; Beau SL
    Am J Cardiol; 1990 Feb; 65(8):56D-64D; discussion 68D-71D. PubMed ID: 2407092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of moricizine in patients with congestive heart failure: a summary of the experience in the United States.
    Pratt CM; Podrid P; Greatrix B; Borland RM; Mahler S
    Am Heart J; 1990 Jan; 119(1):1-7. PubMed ID: 1688682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.
    Podrid PJ; Lyakishev A; Lown B; Mazur N
    Circulation; 1980 Feb; 61(2):450-7. PubMed ID: 7351070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions with Ethmozine (moricizine HCl).
    Kennedy HL; Wood AJ; MacFarland RT
    Am J Cardiol; 1987 Oct; 60(11):79F-82F. PubMed ID: 3310590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
    Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
    Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A symposium: Ethmozine (moricizine HCl)--a new antiarrhythmic agent. April 20, 1985, Montreux, Switzerland. Proceedings.
    Am J Cardiol; 1987 Oct; 60(11):1F-89F. PubMed ID: 3310579
    [No Abstract]   [Full Text] [Related]  

  • 38. [A preliminary report on the antiarrhythmic effect of ethmozine].
    Fang WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Jun; 16(3):154-5. PubMed ID: 3065022
    [No Abstract]   [Full Text] [Related]  

  • 39. Complex ventricular arrhythmias associated with the mitral valve prolapse syndrome. Effectiveness of moricizine (Ethmozine) in patients resistant to conventional antiarrhythmics.
    Pratt CM; Young JB; Wierman AM; Borland RM; Seals AA; Leon CA; Raizner A; Quinones MA; Roberts R
    Am J Med; 1986 Apr; 80(4):626-32. PubMed ID: 3515932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.